SCHEMBL1697388

SCHEMBL1697388

Brc1cc2sc3cc(Br)sc3c2s1

nearest known ligand 0.39

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GPR35 Q9HC97 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12415250 0.85 GPR35 (0.35) GPR35
SCHEMBL10054537 0.85 PKM (0.41) GPR35
SCHEMBL1997385 0.82 GPR35 (0.35) GPR35
SCHEMBL12393160 0.78 GPR35 (0.77) GPR35
SCHEMBL1404133 0.78 GSK3B (0.30)
SCHEMBL17340900 0.77 GPR3 (0.52)
SCHEMBL19220736 0.76
SCHEMBL1992119 0.76
SCHEMBL18876192 0.75 PKM (0.33)
SCHEMBL14608697 0.75 PKM (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025063197-A1 CRYSTAL, METHOD FOR PRODUCING CRYSTAL, AND METHOD FOR INDUCING SELF-ORGANIZATION OF SILANOL COMPOUND 国立研究開発法人産業技術総合研究所 2025-03-27 WO disclosed
US-11370879-B2 Solution-processable indenofluorenes and methods to generate solution-processable indenofluorenes INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2022-06-28 US disclosed
US-11312820-B2 Solution-processable indenofluorenes and methods to generate solution-processable indenofluorenes INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2022-04-26 US disclosed
US-20220081305-A1 CRYSTAL, METHOD OF PRODUCING CRYSTAL, AND METHOD OF SELF-ORGANIZING SILANOL COMPOUND NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 2022-03-17 US disclosed
CN-113195801-A Crystal, method for producing crystal, and method for self-assembling silanol compound 国立研究开发法人产业技术综合研究所 2021-07-30 CN disclosed
US-20210115187-A1 SOLUTION-PROCESSABLE INDENOFLUORENES AND METHODS TO GENERATE SOLUTION-PROCESSABLE INDENOFLUORENES INTERNATIONAL BUSINESS MACHINES CORPORATION 2021-04-22 US disclosed
US-20200190254-A1 SOLUTION-PROCESSABLE INDENOFLUORENES AND METHODS TO GENERATE SOLUTION-PROCESSABLE INDENOFLUORENES INTERNATIONAL BUSINESS MACHINES CORPORATION 2020-06-18 US disclosed
US-20190181348-A1 BRANCH POINT EFFECT ON STRUCTURE AND ELECTRONIC PROPERTIES OF CONJUGATED POLYMERS UNIV CALIFORNIA (US) 2019-06-13 US disclosed
US-10113065-B1 Two-photon absorbing compounds and methods of making same GOVERNMENT OF THE UNITED STATES AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE 2018-10-30 US disclosed
US-9977306-B2 Electrochromic device, optical filter, lens unit, and imaging apparatus CANON KABUSHIKI KAISHA (JP) 2018-05-22 US disclosed
US-20100327273-A1 DITHIENOTHIOPHENE DERIVATIVES NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2010-12-30 US disclosed
WO-2010013002-A1 ORGANIC LIGHT-EMITTING MATERIALS AND DEVICES CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) 2010-02-04 WO disclosed
US-20090247728-A1 COPOLYMERS OF INDENOFLUORENE AND THIOPHENE MERCK PATENT GMBH (DE) 2009-10-01 US disclosed
US-7329896-B2 Polymerizable charge transport compounds MERCK PATENT GMBH (DE) 2008-02-12 US disclosed
US-7329896-B2 Polymerizable charge transport compounds MERCK PATENT GMBH (DE) 2008-02-12 US disclosed
US-7244809-B2 Mono-, oligo- and polymers comprising dithienothiophene and aryl groups MERCK PATENT GMBH (DE) 2007-07-17 US disclosed
EP-1275651-B1 Thienothiophene derivatives MERCK PATENT GMBH (DE) 2005-08-31 EP disclosed
US-6818260-B2 SEMICONDUCTORS, CHARGE TRANSFER COMPOUNDS MERCK PATENT GMBH (DE) 2004-11-16 US disclosed
US-20030021912-A1 Thienothiophene derivatives MERCK PATENT GMBH (DE) 2003-01-30 US disclosed
EP-1275651-A2 Thienothiophene derivatives MERCK PATENT GmbH (DE) 2003-01-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11370879-B2 Solution-processable indenofluorenes and methods to generate solution-processable indenofluorenes INF2, ABL1, ICMT GPR35 2190/4885
US-11312820-B2 Solution-processable indenofluorenes and methods to generate solution-processable indenofluorenes INF2, ABL1, ICMT GPR35 2190/4885
US-20210115187-A1 SOLUTION-PROCESSABLE INDENOFLUORENES AND METHODS TO GENERATE SOLUTION-PROCESSABLE INDENOFLUORENES INF2, ABL1, ICMT GPR35 2190/4885
US-10113065-B1 Two-photon absorbing compounds and methods of making same TBXA2R, TBXAS1, TPD52L2 GPR35 706/4885
US-20200190254-A1 SOLUTION-PROCESSABLE INDENOFLUORENES AND METHODS TO GENERATE SOLUTION-PROCESSABLE INDENOFLUORENES INF2, ABL1, ICMT GPR35 2190/4885
US-20100327273-A1 DITHIENOTHIOPHENE DERIVATIVES TST, SULT1E1, SULT1A1 GPR35 2929/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.